Literature DB >> 16895988

West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody.

Bärbel Kaufmann1, Grant E Nybakken, Paul R Chipman, Wei Zhang, Michael S Diamond, Daved H Fremont, Richard J Kuhn, Michael G Rossmann.   

Abstract

Flaviviruses, such as West Nile virus (WNV), are significant human pathogens. The humoral immune response plays an important role in the control of flavivirus infection and disease. The structure of WNV complexed with the Fab fragment of the strongly neutralizing mAb E16 was determined to 14.5-Angstrom resolution with cryo-electron microscopy. E16, an antibody with therapeutic potential, binds to domain III of the WNV envelope glycoprotein. Because of steric hindrance, Fab E16 binds to only 120 of the 180 possible binding sites on the viral surface. Fitting of the previously determined x-ray structure of the Fab-domain III complex into the cryo-electron microscopy density required a change of the elbow angle between the variable and constant domains of the Fab. The structure suggests that the E16 antibody neutralizes WNV by blocking the initial rearrangement of the E glycoprotein before fusion with a cellular membrane.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16895988      PMCID: PMC1567891          DOI: 10.1073/pnas.0603488103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Physical principles in the construction of regular viruses.

Authors:  D L CASPAR; A KLUG
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

2.  Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

Authors:  J J H Chu; R Rajamanonmani; J Li; R Bhuvanakantham; J Lescar; M-L Ng
Journal:  J Gen Virol       Date:  2005-02       Impact factor: 3.891

3.  Antibody elbow angles are influenced by their light chain class.

Authors:  Robyn L Stanfield; Adam Zemla; Ian A Wilson; Bernhard Rupp
Journal:  J Mol Biol       Date:  2006-01-25       Impact factor: 5.469

4.  West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection.

Authors:  Carl W Davis; Hai-Yen Nguyen; Sheri L Hanna; Melissa D Sánchez; Robert W Doms; Theodore C Pierson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin.

Authors:  Jason Wei-Ming Lee; Justin Jang-Hann Chu; Mah-Lee Ng
Journal:  J Biol Chem       Date:  2005-11-07       Impact factor: 5.157

6.  Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes.

Authors:  Wayne D Crill; Gwong-Jen J Chang
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 7.  West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States.

Authors:  Edward B Hayes; Duane J Gubler
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

8.  Characterization of neutralizing antibodies to West Nile virus.

Authors:  Melissa D Sánchez; Theodore C Pierson; Douglas McAllister; Sheri L Hanna; Bridget A Puffer; Laura E Valentine; Mariam M Murtadha; James A Hoxie; Robert W Doms
Journal:  Virology       Date:  2005-05-25       Impact factor: 3.616

9.  Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.

Authors:  Theodore Oliphant; Michael Engle; Grant E Nybakken; Chris Doane; Syd Johnson; Ling Huang; Sergey Gorlatov; Erin Mehlhop; Anantha Marri; Kyung Min Chung; Gregory D Ebel; Laura D Kramer; Daved H Fremont; Michael S Diamond
Journal:  Nat Med       Date:  2005-04-24       Impact factor: 53.440

10.  Structural basis of West Nile virus neutralization by a therapeutic antibody.

Authors:  Grant E Nybakken; Theodore Oliphant; Syd Johnson; Stephen Burke; Michael S Diamond; Daved H Fremont
Journal:  Nature       Date:  2005-09-29       Impact factor: 49.962

View more
  70 in total

1.  Structure of the three N-terminal immunoglobulin domains of the highly immunogenic outer capsid protein from a T4-like bacteriophage.

Authors:  Andrei Fokine; Mohammad Z Islam; Zhihong Zhang; Valorie D Bowman; Venigalla B Rao; Michael G Rossmann
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.

Authors:  Juergen Zlatkovic; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

3.  Human Monoclonal Fab Antibodies Against West Nile Virus and its Neutralizing Activity Analyzed in Vitro and in Vivo.

Authors:  Tao Duan; Monique Ferguson; Lintian Yuan; Fangling Xu; Guangyu Li
Journal:  J Antivir Antiretrovir       Date:  2009-11-01

4.  Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle.

Authors:  Grant S Hansman; David W Taylor; Jason S McLellan; Thomas J Smith; Ivelin Georgiev; Jeremy R H Tame; Sam-Yong Park; Makoto Yamazaki; Fumio Gondaira; Motohiro Miki; Kazuhiko Katayama; Kazuyoshi Murata; Peter D Kwong
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 5.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Structure of immature West Nile virus.

Authors:  Ying Zhang; Bärbel Kaufmann; Paul R Chipman; Richard J Kuhn; Michael G Rossmann
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Refinement and Analysis of the Mature Zika Virus Cryo-EM Structure at 3.1 Å Resolution.

Authors:  Madhumati Sevvana; Feng Long; Andrew S Miller; Thomas Klose; Geeta Buda; Lei Sun; Richard J Kuhn; Michael G Rossmann
Journal:  Structure       Date:  2018-06-26       Impact factor: 5.006

8.  Impact of quaternary organization on the antigenic structure of the tick-borne encephalitis virus envelope glycoprotein E.

Authors:  Stefan Kiermayr; Karin Stiasny; Franz X Heinz
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

Review 9.  Closing the door on flaviviruses: entry as a target for antiviral drug design.

Authors:  Rushika Perera; Mansoora Khaliq; Richard J Kuhn
Journal:  Antiviral Res       Date:  2008-06-11       Impact factor: 5.970

10.  Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody.

Authors:  Mickaël V Cherrier; Bärbel Kaufmann; Grant E Nybakken; Shee-Mei Lok; Julia T Warren; Beverly R Chen; Christopher A Nelson; Victor A Kostyuchenko; Heather A Holdaway; Paul R Chipman; Richard J Kuhn; Michael S Diamond; Michael G Rossmann; Daved H Fremont
Journal:  EMBO J       Date:  2009-08-27       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.